Maher L - Search Results

1

The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an emulated target trial.

van Santen DK, Boyd A, Matser A, Maher L, Hickman M, Lodi S, Prins M. van Santen DK, et al. Among authors: maher l. Addiction. 2021 Nov;116(11):3115-3126. doi: 10.1111/add.15503. Epub 2021 May 3. Addiction. 2021. PMID: 33788326

2

Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia.

Maher L, Jalaludin B, Chant KG, Jayasuriya R, Sladden T, Kaldor JM, Sargent PL. Maher L, et al. Addiction. 2006 Oct;101(10):1499-508. doi: 10.1111/j.1360-0443.2006.01543.x. Addiction. 2006. PMID: 16968352

3

The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis.

Kwon JA, Iversen J, Maher L, Law MG, Wilson DP. Kwon JA, et al. Among authors: maher l. J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):462-9. doi: 10.1097/QAI.0b013e3181a2539a. J Acquir Immune Defic Syndr. 2009. PMID: 19387355

4

Syringe exchange in the United States: doing the simple things better?

Maher L, Iversen J. Maher L, et al. Addiction. 2009 Sep;104(9):1448-50. doi: 10.1111/j.1360-0443.2009.02602.x. Epub 2009 Jun 24. Addiction. 2009. PMID: 19558566 No abstract available.

5

Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning.

Wand H, Spiegelman D, Law M, Jalaludin B, Kaldor J, Maher L. Wand H, et al. Among authors: maher l. Addiction. 2009 Dec;104(12):2049-56. doi: 10.1111/j.1360-0443.2009.02704.x. Epub 2009 Oct 5. Addiction. 2009. PMID: 19804463

6

Qualitative accounts of needle and syringe cleaning techniques among people who inject drugs in Sydney, Australia.

Nathani J, Iversen J, Shying K, Byrne J, Maher L. Nathani J, et al. Among authors: maher l. Drug Alcohol Rev. 2010 Jul;29(4):413-9. doi: 10.1111/j.1465-3362.2009.00165.x. Drug Alcohol Rev. 2010. PMID: 20636658

7

Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities.

Maher L, White B, Hellard M, Madden A, Prins M, Kerr T, Page K. Maher L, et al. Vaccine. 2010 Oct 21;28(45):7273-8. doi: 10.1016/j.vaccine.2010.08.085. Epub 2010 Sep 9. Vaccine. 2010. PMID: 20831914 Free PMC article. Review.

8

Fifteen years of HIV surveillance among people who inject drugs: the Australian Needle and Syringe Program Survey 1995-2009.

Topp L, Day CA, Iversen J, Wand H, Maher L; Collaboration of Australian NSPs. Topp L, et al. Among authors: maher l. AIDS. 2011 Mar 27;25(6):835-42. doi: 10.1097/QAD.0b013e32834412cc. AIDS. 2011. PMID: 21192232

9

Developing and validating a scoring tool for identifying people who inject drugs at increased risk of hepatitis C virus infection.

Wand H, Iversen J, Wilson D, Topp L, Maher L. Wand H, et al. Among authors: maher l. BMJ Open. 2012 Jan 4;2(1):e000387. doi: 10.1136/bmjopen-2011-000387. Print 2012. BMJ Open. 2012. PMID: 22218720 Free PMC article.

10

HIV and viral hepatitis C coinfection in people who inject drugs: implications of new direct acting antivirals for hepatitis C virus treatment.

Walsh N, Maher L. Walsh N, et al. Among authors: maher l. Curr Opin HIV AIDS. 2012 Jul;7(4):339-44. doi: 10.1097/COH.0b013e328354131e. Curr Opin HIV AIDS. 2012. PMID: 22498482 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

718 results

Search Page

Filters